Atlas FDA

Spectra Optia Apheresis System, REF: 61000, CaridianBCT, Lakewood, CO 80215. The Spectra Optia Apheresis System, a blood

FDA device recall Z-2674-2011 · posted 2011-06-28 · Terminated

Recall details

Recalling firm
Caridian BCT, Incorporated
Reason for recall
An additional air detection system is being added to all existing systems to detect air in the system's return line.
Action taken
CaridianBCT sent a "MEDICAL DEVICE RECALL" letter dated December 2010 to all customers. The letter describes the product, problem, and actions to be taken by the customers. Customers were advised to continue using their systems as long as they followed the instructions in the Operator's Manual. An Acknowledgement of Receipt form was included with the letter to be completed and faxed to 1-303-876-9277 or e-mailed to Regulatory.Affairs@caridianbct.com. A CaridianBCT representative will schedule a visit to facilities to upgrade their systems within the next 6 months. Further information is available by contacting the CaridianBCT Support Center at 877-339-4228 or 303-231-4357.
Root cause
Software design
Status
Terminated
Product code
LKN
Quantity affected
594 units
Distribution
Worldwide Distribution--USA (nationwide) and countries of Australia, Belgium, Canada, China, Hong Kong, Japan, Malaysia, Mexico, Pakistan, Saudi Arabia, Singapore, South Korea, Taiwan, Thailand, and V
Date initiated
2010-12-09
Date posted
2011-06-28
Date terminated
2011-09-12
Location
Lakewood, CO

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
SPECTRA OPTIA R APHERESIS SYSTEM (K103090)Caridianbct, Inc..2010-11-19
SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA EXCHANGE SET, MODEL 61000, 10200 (K071079)Gambro Bct, Inc.2007-08-02